Abstract
Adjuvants that combine TLR agonists and inflammatory agonists promote robust and durable vaccine responses (Bechtold et al. and Arunachalam et al.).
MeSH terms
-
Adjuvants, Immunologic* / therapeutic use
-
Animals
-
Humans
-
Toll-Like Receptors* / agonists
-
Toll-Like Receptors* / immunology
-
Toll-Like Receptors* / metabolism
-
Vaccines / immunology
Substances
-
Adjuvants, Immunologic
-
Toll-Like Receptors
-
Vaccines